Transcend Medical Gets $22M
Menlo Park-based Transcend Medical, a developer of micro-stents used to treat glaucoma, has raised $22M in a Series C funding. The company said the funding came from existing investors, as well as an un-named, global pharmaceutical and medical device company. The firm said the funding will go to support clinical trials. The firm's prior investors include mag, Split Rock Partners, Canaan Partners, Investor Growth Capital, Technology Partners, HLM Venture Partners, Latterell Venture Partners, Kaiser Permanente Ventures, and Finistere Ventures.
posted on Wednesday, April 2, 2014 (Link to more information)
Related companies:
Transcend Fund
Related stories:
> Transcend Medical Sees $51M
> ForSight VISION3 Sees $6M
> Vertos Medical Raises $12M
> Medina Medical Acquired By Medtronic
> Halt Medical Raises $15M
silicontap.com Home